-
-
-
-
-
-
-
Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases
-
-
-
-
-
-
-
Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Reports Efficacy and Safety Data from the Ongoing IGNITE DMD Clinical Trial and Resumption of Patient Dosing in the 2E14 vg/kg Cohort
-
-
-
-
-
-
-
Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Pre-Open Movers 03/15: (SMRT) (RUBI) (CWAY) Higher; (SLDB) (JILL) (SPEX) Lower (more...)
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

